Front Runners: AcelRx Pharmaceuticals (ACRX), Planar Systems (PLNR), Intrexon Corporation (XON), Tesla Motors (TSLA), Summer Infant (SUMR)

AcelRx Pharmaceuticals, Inc. (ACRX) has been a solid gainer in mid-day trading, up more than 12% to $6.77 from Monday’s close of $6.03. The gains have been aided by the company’s narrower net loss in its 3Q 2014 results, and positive Guggenheim comments. AcelRx posted a loss of $0.13 per diluted share, compared to an […] View the full post at: Front Runners: AcelRx Pharmaceuticals (ACRX), Planar Systems (PLNR), Intrexon Corporation (XON), Tesla Motors (TSLA), Summer Infant (SUMR) Related posts: Congress To Hold Hearing on the Circumstances Behind Thursday’s Stock Market Plunge